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CD8+ T cells have been shown to play a critical role in the pathogenesis of experimental
cerebral malaria (ECM) in mice, but their role in development of human cerebral malaria
(HCM) remains unclear. Thus, in this study we have provided the first direct contrast of the
accumulation of CD8+ T cells in the brain during HCM and ECM. HCM cases were from
children who died of Plasmodium falciparum cerebral malaria at Queen Elizabeth Central
Hospital (Malawi) between 2003 and 2010. ECM was induced by infecting C57BL/6J
mice with P. berghei ANKA. We demonstrate similarities in the intracerebral CD8+ T cell
responses in ECM andHCM, in particular an apparent shared choroid plexus—meningeal
route of CD8+ T cell accumulation in the brain. Nevertheless, we also reveal some
potentially important differences in compartmentalization of CD8+ T cells within the
cerebrovascular bed in HCM and ECM.
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INTRODUCTION
Cerebral malaria (HCM) is a severe neurological complication of Plasmodium falciparum (Pf )
infection that despite anti-malarial drug treatment often results in death or disability (1–4).
Sequestration of parasitized red blood cells (pRBCs) within the cerebrovasculature is believed to be
critical for the development of the syndrome in humans (3–6). However, the pathological processes
downstream of pRBC sequestration that drive resultant neuropathology remain unclear (7). The P.
berghei ANKA (Pb ANKA) murine model of experimental cerebral malaria (ECM) model has been
extensively utilized to study the pathogenesis of HCM. In this model, intracerebral CD8+ T cells
play a major role in disruption of the blood brain barrier and formation of cerebral pathology (8, 9).
Whether CD8+ T cells contribute to the development of HCM is unknown and has remained a
matter of significant debate in the malaria community (10).
To address whether CD8+ T cells may play comparable roles during HCM and ECM we have
quantified, by histopathological investigation, CD8+ T cells in human and murine brains during
HCM and ECM, respectively. We examined CD8+ T cell compartmentalization in the cortical
cerebrovasculature, leptomeninges and choroid plexus (CP) to account for the three different routes
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through which T cells can enter and accumulate in the
brain (11): via the blood brain barrier (BBB), the blood-
meningeal barrier (BMB) or the blood-cerebrospinal fluid barrier
(BCSFB), respectively.
MATERIALS AND METHODS
Ethics
The HCM study was approved by research ethics committee
at the University of Malawi College of Medicine P. 11/07/593,
Michigan State University, Liverpool School of Tropical
Medicine (protocol 12.29) and the Royal Liverpool and
Broadgreen University Hospital Trust no. 3690. All research
was performed in accordance with the Declaration of Helsinki.
The ECM study was approved following local ethical review by
the University of Manchester Animal Procedures and Ethics
Committees and was performed in strict accordance with the
U. K. Home Office Animals (Scientific Procedures) Act 1986
(approved H.O. Project License P8829D3B4).
HCM Study Setting
We studied cerebral pathology of a total of 17 Malawian children
by accessing a unique archive of tissue blocks obtained from
a prospective cohort which was recruited between 1996 and
2011 in Blantyre (5, 12, 13). Cases used in this study were
recruited between 2003 and 2010. Autopsies were performed
with parents’ or guardians’ consent as quickly after death as
possible in the morgue of the Queen Elizabeth Central Hospital
in Blantyre, Malawi. Seven children died of clinically and
histopathologically defined CM [2 cases of CM1 and 5 cases
of CM2; for a detailed description of CM classification see
(12)], with Blantyre coma score of ≤2, peripheral P. falciparum
parasitemia, no other obvious cause of coma i.e., hypoglycemia,
post-ictal state, or meningitis, and pRBC sequestration within
cerebral vessels. CM diagnosis was confirmed by presence of
malarial retinopathy (12, 14). We also examined the brains of
5 CM3 cases, which were initially classified as clinical HCM but
which were found to have alternative causes of death (including
pneumonia and intracerebral hematoma), 2 CM7 cases (Non-
malarial encephalopathy, Salmonella sepsis cause of death), 2
CM9 cases and 1 CM11 case (other non-infectious causes of
death, but with incidental parasitemia).
Immunohistochemistry for Human Tissue
At autopsy, the brain was dissected and corresponding,
representative sections from the frontal lobe and choroid
plexus were fixed in 10% neutral buffered formalin, processed,
embedded in paraffin, and sectioned at 3–4 microns. Sections
were stained via the indirect immunoperoxidase method
for CD8 as previously described (5). Briefly, sections were
deparaffinized and rehydrated beforemicrowave antigen retrieval
was performed in Tris EDTA pH9 buffer. After blocking
endogenous peroxidase, sections were incubated with 5%
bovine serum albumin in Tris–Tween 20 buffer at room
temperature for 30min and then incubated with a 1:80
dilution of stock CD8 antibody (C8/144B, mouse monoclonal;
DAKO) overnight at 4◦C. After washing in Tris–Tween 20
buffer, sections were incubated for 1 h with a 1:500 dilution
of goat anti-mouse conjugated to horseradish peroxidase,
before being incubated in 3,3′-diaminobenzidine for 5min, and
counterstained with hematoxylin.
Mice and Infections
Six female 8–10 weeks old C57BL/6 mice were purchased from
Charles River and used for infection, and five C57BL/6 mice were
used as naïve controls. All mice were maintained in individually
ventilated cages at the University of Manchester. Cryopreserved
Pb ANKA parasites clone cl15cy1 (15) were thawed and
passaged once through C57BL/6 mice before being used to infect
experimental animals. Animals were infected via intravenous
injection of 1 × 104 parasitized red blood cells (pRBCs). The
development of ECM was assessed using a well-established
clinical scale (15): 1 = no signs; 2 = ruﬄed fur and/or abnormal
posture; 3= lethargy; 4= reduced responsiveness to stimulation
and/or ataxia and/or respiratory distress/hyperventilation; 5 =
prostration and/or paralysis and/or convulsions. Stages 4–5 were
classified as ECM. P. berghei ANKA infected mice progressed
through stages 1–4 on day 6 of infection and were euthanized
when they reached stage 5 on day 7 of infection, following a
course of infection we have described previously (5).
Immunohistochemistry for Mouse Tissue
Pb ANKA infected mice were killed by CO2, brains removed
and immerse fixed in 4% paraformaldehyde. Brains were then
processed for paraffin embedding, and sectioned at 4µm using a
Leica RM 2155 Microtome (Leica Microsystems Ltd., Germany).
Sections were deparaffinized and rehydrated before undergoing
heat-mediated antigen retrieval (Tris EDTApH 9). After blocking
endogenous peroxidase, sections were incubated with blocking
solution (0.3% Triton-X100 and 1% bovine serum albumin
in PBS) at room temperature for 1 h and then incubated
with a 1:2,000 dilution of stock CD8 antibody (EPR20305,
rabbit monoclonal; Abcam) overnight at 4◦C. Sections were
then incubated in a 1:500 dilution of a biotinylated anti-rabbit
antibody (Vector), followed by a signal amplification step using
a VECTASTAIN Elite ABC HRP Kit (Vector) for 1 h. Sections
were then incubated in 3,3′-diaminobenzidine for 5min, and
counterstained with hematoxylin.
Microscopical Topographical
Quantification of CD8+ Cells
For mouse tissue, images were collected on an Olympus BX63
upright microscope using a 20×/0.75 UApo/340 objective and
captured and white-balanced using a DP80 camera (Olympus)
in color mode through CellSens Dimension v1.16 (Olympus).
For human tissue, images were acquired on a slide-scanner
microscope (Leica) using a 20×/0.30 Plan Achromat objective
(Zeiss). Snapshots of the slide-scans were taken using Aperio
ImageScope (Leica). Images were then processed and analyzed
using Fiji ImageJ (http://imagej.net/Fiji/Downloads). For mice,
8 fields per region (cortex and choroid) were quantified, for
a total area of 2.9 mm2. For each human case, four 4 mm2
fields were quantified in each region, for a total of 16 mm2 per
region. Several parameters were measured to assess CD8+ T cell
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accumulation in each region: absolute number of CD8+ T cells,
proportion of vessels with CD8+ T cells, proportion of CD8+
T cells that have transmigrated across the vascular lumen. In
human cases both parasitized and non-parasitized vessels were
examined. If detected, CD8+ monocytes were not included in
counts, and were distinguishable from lymphocytes due to their
clearly defined kidney-shaped nuclei. Scoring was performed
blinded to CM status by two independent observers, with <10%
intra-observer variation found.
Statistical Analyses
All statistical analyses were performed using GraphPad PRISM
(GraphPad Software). Normality was assessed with Shapiro-Wilk
tests and equal variances with Brown–Forsythe tests. Individual
tests applied are detailed in figure legends.
RESULTS
The comparative histopathology investigation revealed very few
CD8+ T cells within the cortex in both HCM and ECM cases
(Figures 1A,B); however, numbers in ECM were on average
double those in HCM (Figure 1Bi). Although the density of
CD8+ T cells in the cortex was higher in subjects who had
confirmed fatal HCM (CM1 and CM2), compared with control
human non-CM malaria cases (CM3 and CM7), or non-
infectious control cases (CM9 and CM11) (Figures 1Ai,iii,Bi),
within the number of samples examined, the difference was not
statistically significant. In contrast, CD8+ T cell accumulation in
the cortex was significantly higher in ECM than in naïve mice
(Figures 1Ai,iii,Bi).
In both ECM and HCM CD8+ T cells were observed most
frequently singular and associated with capillaries (classified by
FIGURE 1 | Distribution of intracerebral CD8+ T cells in the cortex in HCM and ECM. The presence of intracerebral CD8+ T cells was assessed by
immunohistochemistry in fatal HCM cases, in C57BL/6 mice that developed late-stage ECM after Pb ANKA infection, and in appropriate controls. (A) Representative
images from HCM and ECM cases showing (Ai) low magnification and (Aii) high magnification identification of both luminal (black arrows) and perivascular (gray arrows)
CD8+ T cells, in capillaries and large caliber vessels. (Aiii) Representative images showing lack of CD8+ T cells in brains of HCM controls (CM9) and naïve mice. (B)
Several parameters of CD8+ T cell accumulation were quantified: (Bi) absolute numbers of CD8+ T cells per mm2, (Bii) percentage of total vessels with CD8+ T cells
(either luminal or perivascular), (Biii) percentage of CD8+ T cells that were perivascular, (Biv) percentage of vessels in HCM cases with CD8+ T cells separated into
vessels with and without parasitized red blood cells (pRBCs). HCM = CM1 (filled circles) and CM2 (open circles) cases, Non-HCM = CM3 (filled circles) and CM7
(open circles), Non-Inf = CM9 (filled circles) and CM11 (open circles). (C) Representative images from HCM cases and ECM samples showing: (Ci) intracerebral
hemorrhage (white arrows indicate red blood cells, note classical ring hemorrhage in HCM, demarcated by dotted outline), areas of vasogenic edema (asterisks)
without (Cii) and with CD8+ T cells (Ciii). Scale bars = 50µm. *p < 0.05. Human cases were compared by one-way ANOVA with Holm-Sidak’s multiple comparisons
test, ECM was compared to naïve by Student’s t-test, and presence of CD8+ T cells in pRBC positive and negative vessels was compared by Student’s t-test.
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measuring vessel diameter) (Figure 1Aii). However, multiple
CD8+ T cells were occasionally found associated with non-
capillary (larger-caliber) vessels, which were often packed with
RBCs and leukocytes (Figure 1Aii). Interestingly, on average,
4% of cortical blood vessels in HCM and ECM brains were
positive for CD8+ T cells (Figure 1Bii). The increased density of
CD8+ T cells in ECM compared with HCM was, therefore, not
because CD8+ T cells were associated with a higher percentage of
vessels, but was because there was a greater frequency of packed
vessels with clusters of CD8+ T cells in ECM. In HCM, blood
vessel-associated CD8+ T cells in the cortex were predominantly
perivascular (i.e. had crossed the BBB but not passed the glial
limitans or penetrated into parenchyma), whereas in ECM they
were predominantly luminal (Figures 1Aii,Biii). There was no
significant difference in the percentage of pRBC positive and
pRBC negative vessels associated with CD8+ T cells during
HCM, indicating that pRBC presence does not promote or
impede CD8+ T cell accumulation during HCM (Figure 1Aiv).
Notably, in neither the HCM nor ECM cases examined were
spatial relationships between CD8+ T cells and pathological
features apparent: Perivascular edema was observed in vessels
with and without CD8+ T cells, and there was a lack of CD8+
T cells at sites of hemorrhage (Figure 1C).
CD8+ T cells were observed throughout the leptomeninges in
both HCM and ECM samples (Figure 2A). CD8+ T cells were
found in the lumen of pial vessels, and within the cerebrospinal
fluid (CSF)-filled subarachnoid space (SAS), in qualitatively
higher numbers than in the cortex (Figure 2A). The choroid
plexus has been shown to be a major route for T cell trafficking
via the ventricles to the leptomeninges (11, 16). In agreement
with this there was a significant accumulation of CD8+ T cells
in the CP during ECM (compared with uninfected controls)
and, within the small number of cases examined, there was a
trend toward higher numbers of CD8+ T cells in the CP during
HCM, compared with non-infectious controls (Figures 2B,Ci).
The density of CD8+ T cells was also significantly higher in
the CP than in the cortex in ECM samples (11.9 in cortex,
24.4 in CP, p = 0.039), and trended higher in HCM cases
(6.2 in cortex, 12.4 in CP, p = 0.076). In both ECM and
HCM, CD8+ T cells were observed in the lumen of CP
blood vessels, but were also found in the stroma, or to have
transmigrated into the ventricles (Figures 2B,Cii; black or gray
FIGURE 2 | Distribution of CD8+ T cells in the leptomeninges and choroid plexus in HCM and ECM. The presence of CD8+ T cells in the leptomeninges and choroid
plexus was assessed by immunohistochemistry in fatal HCM cases, in C57BL/6 mice that developed late-stage ECM after Pb ANKA infection, and in appropriate
controls. (A) Representative images of the leptomeninges from HCM and ECM cases showing CD8+ T cells in the lumen of pial vessels (black arrows), and in the
subarachnoid space (gray arrows). (B) Representative images of the choroid plexus from HCM and ECM cases showing CD8+ T cells in the stroma or lumen
(asterisks) of blood vessels (black arrows), or that have transmigrated into the ventricle (gray arrows; white triangle indicates CSF-filled ventricle). (C) (Ci) Absolute
numbers of CD8+ T cells per mm2 of choroid plexus; (Cii) percentage of CD8+ T cells in the choroid plexus that had transmigrated into the ventricle. HCM = CM1
(filled circles) and CM2 (open circles) cases, Non-HCM = CM3 (filled circles) and CM7 (open circles), Non-Inf = CM9 (filled circles) and CM11 (open circles). Scale
bars = 50µm. *p < 0.05. Human cases were compared by one-way ANOVA with Holm-Sidak’s multiple comparisons test, ECM was compared to naïve by
Students t-test.
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arrows, respectively). Thus, our results suggest a comparable
choroid plexus–meningeal route of CD8+ T cell entry into the
superficial areas of the brain may be present in both ECM
and HCM.
DISCUSSION
In this study we have confirmed the presence of CD8+ T
cells in both HCM and ECM brain pathology, but that very
few CD8+ T cells are required in the cerebrovasculature for
development of ECM, where they play a known important
role in disease pathogenesis (8, 9). This observation redefines
the expectations of the numbers of CD8+ T cells that should
be seen in HCM. Whilst we only examined CD8+ T cell
accumulation within the cortex in HCM and ECM brains
within this study, we have previously shown that CD8+ T cell
numbers are highest in the cortex during ECM compared with
other brain regions, including the brain stem and olfactory
bulbs. Moreover, there is also a high level of pathology
within the cortex, compared with other brain regions, during
both HCM and ECM (5, 15). CD8+ T cell numbers were
heterogeneous in the different HCM cases, which may relate
to the fact CM1 and CM2 are distinct syndromes (5), as well
as temporal differences in course of infection and timing of
death of the different patients. The assessment of additional
CM1 and CM2 cases would be required to definitively address
the contribution of these parameters in controlling CD8+ T
cell numbers within the brain during HCM. Whether the
administration of anti-malarial drugs (and the duration from
treatment) influenced intracerebral CD8+ T cell numbers in
HCM cases, or affected the comparison with ECM samples,
where mice did not receive any treatment, also requires further
investigation. Nevertheless, overall, from the number of HCM
cases examined, our results suggest that the density of CD8+ T
cells in the brain during ECM may be higher than in HCM CM1
and CM2 cases.
We observed CD8+ T cells in a comparably low percentage
of vessels during ECM and HCM. Whilst this may suggest that
CD8+ T cells equally influence the cerebrovascular network in
ECM and HCM, CD8+ T cells were primarily luminal in the
cortex in ECM, as previously reported (15, 17). In contrast,
CD8+ T cells were predominantly perivascular within the brain
in HCM. The reason for the difference in compartmentalization
of CD8+ T cells between ECM and HCM is unclear as activation
of cerebral endothelial cells appears similar in HCM and ECM
(7, 8, 18), and both human and murine brain endothelial
cells seem able to phagocytose and present Plasmodium spp.
antigens for recognition by CD8+ T cells (19, 20). Further
work will thus be required to investigate if CD8+ T cells
interact differently with the vascular endothelial cells during
ECM and HCM, and if the contrasting compartmentalization
means CD8+ T cells have differing importance during the HCM
and ECM syndromes.
Our results suggest a comparable choroid plexus–meningeal
route of CD8+ T cell entry into the superficial areas of
the brain may be present in both ECM and HCM. In
qualitative analyses the density of CD8+ T cells was higher
in the leptomeninges than in the cortex during HCM and
ECM, and the numbers of CD8+ T cells in the CP was
significantly higher and trended higher than in control
samples during ECM and HCM, respectively. The CP is
an important entry point into the CSF containing SAS
where T cell immunosurveillance of the CNS occurs (11,
16). Thus, activated T cells accumulate in the SAS and are
exposed to material in the interstitial fluid drained to this
site via the glymphatics system (21). Whilst, the relative
importance of CD8+ T cells located within the choroid
plexus and leptomeninges in the pathogeneses of ECM and
HCM is unknown, it has recently been shown that meningeal
inflammation can lead to CXCL10 production that signals
inward to the brain parenchyma affecting neuronal function
(22). CXCL10 is involved in the pathogenesis of ECM, including
through promoting T cell migration and stabilizing T cell
adhesion to brain endothelial cells (23, 24), and has been
associated with HCM development (25). Therefore, it is possible
that the accumulation of CD8+ T cells within the choroid
plexus and leptomeninges may trigger inward transmission
of inflammatory signals, potentially through the CSF-filled
perivascular spaces, contributing to malaria-induced cerebral
pathology. The presence of CD8+ T cells in the CP in
CM3 and CM7 cases may be because these patients died of
conditions with a known inflammatory element (e.g., non-
malarial encephalopathy). In support of this, CD8+ T cells were
rarely found in the CP of patients with non-infectious causes of
death, or in naïve mice.
In conclusion, in this first direct comparative study we
demonstrate CD8+ T cells are observed in very low numbers
in both ECM and HCM, and that CD8+ T cells are associated
with a comparable proportion of blood vessels in HCM and
ECM. Nevertheless, there are important differences in the
compartmentalization of CD8+ T cells in HCM and ECM, which
may influence the relative role of the cells in the two syndromes.
Further investigations into the impact of CD8+ T cells, and
other immunological mediators, in the leptomeninges tomalaria-
induced encephalopathy are warranted.
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